about
Ephs and Ephrins in malignant gliomasHomotypic receptor-receptor interactions regulating Eph signaling.In silico analyses and global transcriptional profiling reveal novel putative targets for Pea3 transcription factor related to its function in neurons.EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins.EphA8 is a prognostic marker for epithelial ovarian cancer.Paradoxes of the EphB1 receptor in malignant brain tumors.EphA3 biology and cancer.Eph family co-expression patterns define unique clusters predictive of cancer phenotype.Multifunctional nanodiamonds in regenerative medicine: Recent advances and future directions.Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.Silencing of CtBP1 suppresses the migration in human glioma cells.Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells.UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous system
P2860
Q27015780-70C0A0A0-5437-4160-8BA6-798D4111C558Q36125047-FD9105B0-C5B5-49F8-88BF-301E566F306DQ36269696-FE71B287-1123-44F8-867F-14FBC0056558Q36934491-EA9A259C-B1D6-43D4-84CC-24F20D7EC725Q37190444-B7624E1B-549E-4FF4-B528-F83064B99A70Q37633690-7B7D2B5C-F625-4677-8C45-EC3B4794A535Q38267753-D560B76D-2993-4C80-A9AC-EFB9B4819AE4Q38269791-58C45FB0-8C6C-4AD9-BA8F-0C7303B7478DQ38673088-F2D68067-3518-446B-B4CD-226AC9E99EACQ38731795-31C731C3-63C6-4FA1-993B-F81161878E90Q38772235-D2CEE2C2-9035-4BD7-AD60-02B26A42587BQ38838986-85838EFC-1D33-4956-BDAA-00E871BBBAE8Q42371545-0E5C193D-8394-45C0-941F-51723B072BB3Q42529862-02D0CE94-AECA-48E0-A8AA-901391202080Q54946129-0CC97D58-1B9D-4379-8A2C-756DE45C53EAQ55286883-438C5665-17BA-4780-9AB1-D5735DF927CDQ58805400-2F66FBC5-8F30-4D5A-ADE3-AD8A9F058004
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Eph receptors as therapeutic targets in glioblastoma
@ast
Eph receptors as therapeutic targets in glioblastoma
@en
Eph receptors as therapeutic targets in glioblastoma
@nl
type
label
Eph receptors as therapeutic targets in glioblastoma
@ast
Eph receptors as therapeutic targets in glioblastoma
@en
Eph receptors as therapeutic targets in glioblastoma
@nl
prefLabel
Eph receptors as therapeutic targets in glioblastoma
@ast
Eph receptors as therapeutic targets in glioblastoma
@en
Eph receptors as therapeutic targets in glioblastoma
@nl
P2860
P921
P3181
P356
P1476
Eph receptors as therapeutic targets in glioblastoma
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/BJC.2014.73
P407
P5008
P577
2014-08-21T00:00:00Z
P5875
P6179
1009113029